Eurofins Advinus

Eurofins Advinus

Bangalore, India· Est.

A leading Indian preclinical CRO/CDMO offering end-to-end drug discovery and development services for small molecules, with a strong focus on regulatory compliance and global client support.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

A leading Indian preclinical CRO/CDMO offering end-to-end drug discovery and development services for small molecules, with a strong focus on regulatory compliance and global client support.

Broad Service Provider

Technology Platform

Integrated preclinical service platform emphasizing regulatory-driven, phase-appropriate process development, employing QbD/DoE methodologies, advanced analytical chemistry (LC-MS/MS, prep-HPLC), and over 30 years of GLP-compliant study conduct.

Opportunities

Growth through deeper integration with the Eurofins global network, expansion of biologics and medical device testing services, and capitalizing on the increasing outsourcing of preclinical R&D to cost-effective, high-quality Indian CROs.

Risk Factors

Intense competition from other global and Indian CROs/CDMOs, reliance on the broader pharmaceutical R&D spending cycle, and operational risks associated with maintaining consistent quality and regulatory compliance across a diverse service and client portfolio.

Competitive Landscape

Competes with global CROs like Charles River Laboratories, Labcorp, and ICON, as well as Indian peers like Syngene and Sai Life Sciences. Differentiates through its long-standing GLP heritage, integrated 'discovery-to-CDMO' offering within the Eurofins ecosystem, and proven track record in supporting US FDA IND approvals.